Pruritus Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on "Pruritus - Market Insights, Epidemiology, and Market Forecast-2030".
DelveInsight's "Pruritus -
Market Insights, Epidemiology, and Market Forecast-2030" report
delivers an in-depth understanding of the Pruritus, historical and forecasted
epidemiology as well as the Pruritus market trends in the United States, EU5
(Germany, Spain, Italy, France, and United Kingdom) and Japan.
·
A 2013 study by Shive et al. reported 77 million
visits for itch in America over an 11-year period, with an average of 7 million
visits per year, accounting for roughly 1 % of all physician visits.
·
According to the study published by Nicholas et
al., the prevalence of pruritus in the general population varies from 8 to 38 %
worldwide.
·
The study published by Laurent et al., suggested
that in the database maintained by the Münster Competence Centre of Chronic
Pruritus, 8% of cases of chronic itch could be associated with a neuropathic
origin.
·
As per the study by Emilie et al., the
prevalence of patients experiencing pruritus following a burn injury has been
noted to be as high as 93%. 70–83% of patients continue to be affected by
pruritus 1 year after their burn injury, and 67–73% are affected 2 years
post-burn injury.
- The
report covers the descriptive overview of Pruritus, explaining its causes,
signs and symptoms, pathophysiology, diagnosis and currently available
therapies
- Comprehensive
insight has been provided into the Pruritus epidemiology and treatment in
the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for Pruritus
are provided, along with the assessment of new therapies, which will have
an impact on the current treatment landscape
- A
detailed review of Pruritus market; historical and forecasted is included
in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Pruritus market
View Report: https://www.delveinsight.com/report-store/pruritus-market
Request for free
sample report: https://www.delveinsight.com/report-store/pruritus-market
Pruritus,
or itching, although considered a benign symptom, is a frequent complaint heard
by dermatologists and primary care physicians. It can have adverse effects on a
patient’s wellbeing and can be incapacitating when severe.
The mechanisms of pruritus are not particularly well
understood and are compounded by the subjective nature of the process itself.
The condition occurs with a host of dermatological conditions, but can also be
a marker of systemic disease.
Physiologically, itching is the conscious expression of
cutaneous sensations that evoke the well-known scratch reflex. The purpose of
this reflex is the removal of the noxious stimulus. Unfortunately, scratching
can cause further damage to the skin and can perpetuate the problem. Severe
pruritus can be relieved by self-trauma, essentially replacing itching with
pain, but such action can result in chronic skin changes, such as
lichenification, erythema, excoriation, and even lacerations.
Pruritus may be acute or chronic, localized or generalized.
Chronic pruritus of unknown origin is defined as pruritus lasting six weeks or
longer with no identified underlying cause. Chronic itch is defined as itch
lasting more than 6 weeks and represents a veritable quagmire for clinicians,
as it causes significant emotional distress in patients with negative effects
on quality of life and sleep and is often difficult to treat.
View Report: https://www.delveinsight.com/report-store/pruritus-market
Request for free
sample report: https://www.delveinsight.com/report-store/pruritus-market
·
Menlo Therapeutics
·
Cara Therapeutics
·
Trevi Therapeutics
·
And Many Others
·
Serlopitant
·
CR845
·
Nalbuphine ER
·
And Many Others
View Report: https://www.delveinsight.com/report-store/pruritus-market
Request for free
sample report: https://www.delveinsight.com/report-store/pruritus-market
1. Key Insights
2. Executive Summary
of Pruritus
3. Competitive
Intelligence Analysis for Pruritus
4. Pruritus: Market
Overview at a Glance
4.1. Pruritus Total Market Share (%) Distribution in 2017
4.2. Pruritus Total Market Share (%) Distribution in 2030
5. Pruritus: Disease
Background and Overview
6. Patient Journey
7. Pruritus
Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
8.1. Pruritus Treatment and Management
8.2. Pruritus Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of
Pruritus Treatment
11. Marketed
Products
List to be continued in report
12. Emerging
Therapies
List to be continued in report
13. Pruritus: Seven
Major Market Analysis
13.1. Key Findings
13.2. Pruritus Market Size in 7MM
13.3. Pruritus Market Size by Therapies in the 7MM
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Pruritus
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
View Report: https://www.delveinsight.com/report-store/pruritus-market
About DelveInsight
DelveInsight is a
premier Business Consulting and Market Research firm focused exclusively on the
life science segment. With a wide array of smart end-to-end solutions, the firm
helps the global Pharmaceutical and Bio-Tech companies formulate prudent
business decisions for
Browse through our
vast repository from here.
Media Contact
Company Name: DelveInsight
Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment